Chimeric Antigen Receptor News and Research

RSS
Metabolites of intestinal bacteria can positively influence the efficacy of tumor therapies

Metabolites of intestinal bacteria can positively influence the efficacy of tumor therapies

Promising immunotherapy uses cancer-killing cells to destroy malignant tumors

Promising immunotherapy uses cancer-killing cells to destroy malignant tumors

Mayo Clinic researchers are working toward new CAR-T cell treatment for multiple myeloma

Mayo Clinic researchers are working toward new CAR-T cell treatment for multiple myeloma

Different comorbid conditions in COVID-19 patients can impact outcomes of positive PCR test results

Different comorbid conditions in COVID-19 patients can impact outcomes of positive PCR test results

UC San Diego Health offers new immunotherapy treatment for multiple myeloma following FDA approval

UC San Diego Health offers new immunotherapy treatment for multiple myeloma following FDA approval

Moffitt Cancer Center presents new data from dozens of clinical research studies at ASCO

Moffitt Cancer Center presents new data from dozens of clinical research studies at ASCO

Novel approach to immunotherapy design could pave the way for new brain cancer treatments

Novel approach to immunotherapy design could pave the way for new brain cancer treatments

Arresting tumor growth for a variety of cancers through T cell engineering

Arresting tumor growth for a variety of cancers through T cell engineering

Researchers receive $3.75 million to study the impact of fluid flow on CAR-T cell therapy for brain cancer

Researchers receive $3.75 million to study the impact of fluid flow on CAR-T cell therapy for brain cancer

Stem cell transplants offer long-term benefits for pediatric cancer patients receiving immunotherapy

Stem cell transplants offer long-term benefits for pediatric cancer patients receiving immunotherapy

First cell-based gene therapy approved by the FDA for treating multiple myeloma

First cell-based gene therapy approved by the FDA for treating multiple myeloma

Moffitt researchers use mathematical modeling to help explain outcomes of CAR T-cell therapy

Moffitt researchers use mathematical modeling to help explain outcomes of CAR T-cell therapy

Study explores how CAR T immunotherapy could be used to treat solid tumors

Study explores how CAR T immunotherapy could be used to treat solid tumors

CAR T-cell therapy triples expected length of remission for relapsed multiple myeloma patients

CAR T-cell therapy triples expected length of remission for relapsed multiple myeloma patients

Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects

Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

ACGT awards $500,000 to advance immunotherapy approach for treating solid tumors

ACGT awards $500,000 to advance immunotherapy approach for treating solid tumors

AI-based 3D holographic microscopy found to be better at analyzing cancer immunotherapy​

AI-based 3D holographic microscopy found to be better at analyzing cancer immunotherapy​

Understanding the dynamics of brain blood flow could hold key for treating neurologic conditions

Understanding the dynamics of brain blood flow could hold key for treating neurologic conditions

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas